TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
SRPT

Sarepta Therapeutics Inc

Healthcare · Biotechnology

18.70$ +1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow SRPT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-3.21 -3.53 -5.05 -3.94 -5.87 -6.20 1.38 -5.45 -3.72 -5.42 -1.91 -1.96
0.09 0.12 0.12 0.14 0.18 0.33 0.35 0.47 0.48 0.48 0.35 0.42
0.51 0.76 0.62 0.52 0.76 1.07 1.39 1.40 2.66 1.98 1.71 1.18
0.58 0.77 0.63 -1.55 1.16 3.72 2.28 0.39 4.29 – – –
-0.55 0.76 -0.32 -1.66 -1.63 -0.91 7.11 -1.21 -0.45 -5.21 -6.64 0.74
0.67 0.11 0.14 0.36 0.97 0.81 1.05 0.47 0.37 0.95 1.36 0.97
-3.97 0.20 -1.85 -3.04 -5.59 3.89 -1.56 6.10 -11.96 -1.79 7.00 0.66
0.00 0.00 0.00 0.00 – 3.27 3.67 – – – – –
2.60 3.09 7.49 6.02 8.51 -0.06 -0.06 -0.10 – 0.00 0.00 -0.24
0.00 0.40 -0.16 9.69 -0.05 3.33 3.73 3.74 3.47 0.00 0.00 -1.55
2.60 3.50 7.76 15.10 8.00 8.73 8.75 6.91 2.66 1.35 1.16 -1.61
-4.58 0.16 0.86 8.11 -3.46 6.42 8.57 7.55 -13.02 -5.86 6.25 -2.90
-3.88 -3.65 -5.19 -4.30 -6.84 -7.01 0.32 -5.93 -4.08 -6.37 -3.27 -2.93

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?